סיפרול 0.75 er
rafa laboratories ltd - pramipexole dihydrochloride monohydrate 0.75 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
סיפרול 1.5 er
rafa laboratories ltd - pramipexole dihydrochloride monohydrate 1.5 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
תרימקסול 0.25
trima israel pharmaceutical products maabarot ltd - pramipexole dihydrochloride monohydrate 0.25 mg - tablets - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa. for symptomatic treatment of moderate to severe idiopathic restless legs syndrome.
תרימקסול 1
trima israel pharmaceutical products maabarot ltd - pramipexole dihydrochloride monohydrate 1 mg - tablets - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with lovodopa.
פרמיפקסול טבע ® 0.25 מ"ג
salomon,levin & elstein ltd - pramipexole dihydrochloride monohydrate 0.25 mg - tablets - pramipexole - treatment of the signs and symptoms of idiopathic parkinson's disease, it may be used as monotherapy or in combination with levodopa, as well as symptomatic treatment of moderate to severe idiopathic restless legs syndrome.
פרמיפקסול טבע ® 1 מ"ג
salomon,levin & elstein ltd - pramipexole dihydrochloride monohydrate 1 mg - tablets - pramipexole - treatment of the signs and symptoms of idiopathic parkinson's disease, it may be used as monotherapy or in combination with levodopa.
סיפרול er 4.5 מ"ג
rafa laboratories ltd - pramipexole dihydrochloride monohydrate 4.5 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson’s disease, as monotherapy or in combination with lovodopa.
טופרניל 25 מ"ג טבליות
novartis pharma services ag - imipramine hydrochloride 25 mg - tablets - imipramine - treatment of various types of depression. in children and adolescents there is not sufficient evidence of safety and efficacy of tofranil in the treatment of all forms of depression. the use of tofranil in children and adolescents ( 0 - 17 years of age) in these indications is therefore not recommended.
סורמונטיל 25 מ"ג
sanofi - aventis israel ltd - trimipramine as maleate 25 mg - tablets - trimipramine - antidepressant.
multiplate and accessories
מדיסון פארמה בע"מ - צוות טכני - for diagnostic of antagonism to aspirin, clopidogrel, prasugrel, iibiiia antagonist and platelet disorders